Introduction
We utilized in vivo 3tPhosphorous magnetic resonance spectroscopy (3tp MRS) to deterraine whether acute administration of diazepam alters brain oxidative and phospholipid metabolism in normal subjects. A primary motivation for these experiments was to establish whether sedation with diazepam, which is often required for patients to be successfully studied with MRS, alters 3~p metabolites. We present here the results of an initial study of eight subjects using 10 mg of diazepam and a second study of ten subjects using 20 mg of diazepam.
Methods
Eight men who were volunteers (mean _ SD ---28.4 _ 4.8 years) participated in the 10 mg study, and 9 men and I woman (mean __. SD 27.8 ~ 4.4 years) participated in the 20 mg study. One subject participated in both studies. All subjects were fr~e of medical, neurological, er psychiatric problems and denied a history of ~.lcohol or su~stanc~ abuse. None were taking any medication at ti~e time of the study. All subjects underwent a control 31p MRS study in the fasting state, followed by their dosage of oral diazepam and a repeat sip MRS study I hr hater. All studies were performed on a Philips Gyroscan 2.0 Tesla S15 MRI/MRS system, operating at 34.79 MHz for 3tPhosphorus. Subjects underwent Tt-weighted (TR = 600 msec; TE := 30 msec) sagittal and multislice axial images on which two spectroscopy volumes of interest (VOls) were determined (see Figure 1 ). The first, (Region A, 127 ml, 8.5 × 6 × 2.5 cm 3) consisted mainly of white matter, and was bordered inferiorly by the inferior margin of the corpus callosum and by the inner mat'gin of the cortical mantle. The second, (Region B, 90 ml, 5 × 6 × 3 cm 3) consisted primarily of subco~cal gray matter structures with minimal white matter from the extreme, external, and internal capsules. This region was bounded anteriorlyinferiorly by sphenoid bone; third and inferior lateral ventricle cerebrospinal fluid (CSF) was included in this volume.
Using the improved ISIS sequence (Matson et al 1988) , 3ip spectra of the VOI were acquired with a 16.5 cm diameter Helmholtz head coil for 640 scans with a repetition time of 2 se~. Absolute molar concentrations were estimateA as previously described (Roth et al 19~?; L~wry et al 1989; Deicken et al 1991) .
Statistical Analysis:
To test for changes due to diazepam, the Wilcoxon test was applied to metabolite concentrations, ratios of concentrations, and pH, separately for data from the 10 mg a~ld 20 mg studies.
In the second stage of analysis, we combined the data from the two studies, ir~creasing the precision of the statistical estimates. We first computed the postdiazepam to pn..diazepam ratio of each metabolite concentration and pH. We assumed a linear regression model of the form: log(Ro) = [~j + e~, i = 1,..., nj, j= i,2, in which log denotes the natural logarithm, j is the dose of diazepam measured in tens of milligrams, (e.g., j = 2 denotes a dose of 20 mg), is a regression coefficient, and e o denotes random error. We assumed that the errors were independent and normally distributed, neglecting possible dependence between measurements on the one subject that appeared in both studies.
The model had no intercept, corresponding to an assumption of no effect of a zero dose. The data from the 10 mg study were considerably more variable than those in the 20 mg study, due to periodic Gyroscan preamplifier variation that was resolved before we undertook the 20 mg study. To account for this, we used weighted least squares (WLS) (Draper and Smith 1966) .
We computed ,:onfidence intervals for the percentage change in [PCr] and [13-ATP], the two metabolite concentrations we judged to have the greatest potential clinical importance. We applied the Bonferroni correction based on computing four intervals (two metabolites by two brain regions).
Results
For both the I0 mg and 20 mg study (Table 1) , the Wilcoxon tests revealed no significant differences in metabolite concentrations, ratios, or pH in either Region A or Region B as a consequence of diazepam administration. Table 2 (top) gives the estimated percentage change caused by increasing the diazepam dose by I0 rag. All the change estimates in Table 2 are very close to zero, giving further evidence that diazepam has little or no effect on these metabolites and pH. 
Discussion
Our study suggests that oral administration of a single dose of diazepam up to 20 mg does not significantly alter brain high energy phosphorous or phospholipid metabolism as detected by in vivo 3~p MRS in either a primarily white matter or a subcortical gray matter region. Thus, diazepam can be utilized to sedate patients when necessary for 31p MRS studies without having an appreciable effect on 3ap metabolites. To our knowledge, this is the first in vivo MRS report to examine the effect of a sedative hypnotic on brain high energy phosphorous metabolism. Because brain MRS studies require that a patient lie recumbent in the magnet for 2-4 hr, such studies have been difficult to perform on elderly patients, medically ill patients, psychiatric patients, and subjects with mild claustrophobia. The ability to premedicate subjects with diazepam will facilitate study of these populations without significantly affecting 31p MRS measures.
There are several limitations to the "~P MRS measurements. MRS volume selection techniques such as ISIS are subject to a "resonance offset" phenomenon that results in a slight shift in the actual VOI for each metabolite. Second, the tissue within the VOI was assumed to be homogeneous. Third, the T~s used to calculate concentrations were derived from normal subjects for large brain volumes that were less homogeneous than the VOls of the current study. Lastly, a uniform tissue water ,;ontent was assumed for all subjects. If the water content varied among subjects, that could have affected the concentrations; however, this could not have accounted for our results as all metabolites would have been affected equally. The limitations of our methodology and the use of these simplifying assumptions argues for caution in the interpretation of our results.
